35
2023-05-09 18:52:40
Biogen has announced the availability in Italy of the new low-volume, citrate-free formulation of its biosimilar drug adalimumab, indicated in the European Union for the treatment of immune-mediated chronic inflammatory diseases that affect over 2 million people in Italy. The more comfortable injection procedure offered by the drug promotes greater patient compliance
#Immunemediated #chronic #inflammatory #diseases #Biogen #biosimilar #formulation #comfortable #injection #procedure